Lazertinib US FDA Label

  • Compound: N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide
  • Description: NA
  • Brand Name:
  • Code(s): GNS1480
  • Approved:
  • Kinase Class: RY
  • Inhibitor Type: VI
  • Literature (PubMed): 0
  • Target(s):
  • Disease(s):

Identifiers (5)

  • International Nonproprietary Name: LAZERTINIB [INN] (Source: PubChem)
  • KEGG Drug ID: D11980 (Source: PubChem)
  • SureChEMBL ID: SCHEMBL17670400 (Source: PubChem)
  • USFDA Precision ID: UNII-4A2Y23XK11 (Source: PubChem)
  • US Adopted Name: Lazertinib [USAN] (Source: PubChem)

    • Sources: PubChem (5)